Significance of coexpression of urokinase-type plasminogen activator, and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectal carcinoma

Journal of Surgical Research

Volumn 93, Issue 2, 2000, Pages 211-218

  Inuzuka, Kiyohisa ^a   Ogata, Yutaka ^a   Shirouzu, Kazuo ^a   Nagase, Hideaki ^b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Colorectal carcinoma; MMP 3; MMP 9; uPA

Indexed keywords

GELATINASE B; PLASMIN; STROMELYSIN; UROKINASE;

ARTICLE; CANCER GROWTH; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME MECHANISM; FEMALE; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE;

EID: 0033779222     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2000.5952     Document Type: Article

References (32)

1. The pathogenesis of cancer metastasis
2. Immunohistochemical distribution of typeIV collagenase in normal, benign, and malignant breast tissue
3. TypeIV collagenase (Mr 72, 000) expression in human prostate: Benign and malignant tissue
4. Messenger RNA for two typeIV collagenases is located in stromal cells in human colon cancer
5. TypeIV collagenases in tumor invasion and metastasis
6. Metalloproteinases and cancer invasion
7. Prognosis of gastric carcinoma revealed by interactions between tumor cells and basement membrane
8. Overexpression of matrix metalloproteinse-7 mRNA in human colon carcinomas
9. Matrix metalloproteinases and their inhibitors in connective tissue remodeling
10. Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family
11. Cloning of the cDNA encoding human tissue inhibitor of metalloproteinase-3 (TIMP-3) and mapping of the TIMP-3 gene to chromosome 22
12. Molecular cloning and characterization of human tissue inhibitor of metalloproteinse 4
13. Furin-dependent intracellular activation of the human stromelysin-3 zymogen
14. A metalloproteinase expressed on the surface of invasive tumour cells
15. Substrate specificities and activation mechanisms of matrix metalloproteinases
16. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinse 9
17. Step involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinase-1 complex by 4-aminophenylmercuric acetate and proteinases
18. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion
19. A prospective clinicopathologic study of venous invasion in colorectal cancer
20. Carcinomatous lymphatic permeation. Prognostic significance in patients with rectal carcinoma - A long term prospective study
21. Matrix metalloproteinase 9 (92-kD gelatinase/typeIV collagenase) is induced in rabbit articular chondrocytes by cotreatment with interleukin1β and a protein kinase C activator
22. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors
23. Analysis of protein and peptide mixtures. Evaluation of three sodium dodecyl sulphate-polyacrylamide gel electrophoresis buffer systems
24. Substrate specificities and activation mechanisms of matrix metalloproteinases
25. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells
26. Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells
27. The expression of urokinase type plasminogen activator is a novel prognostic factor in dukes B and C colorectal cancer
28. Urokinase-type plasminnogen activator and plasminogen activator inhibitor-1 as a prognostic factor in human colorectal carcinomas
29. Stromelysin/transin and tumor progression
30. Stromelysin-1 is expressed in stromal cells as well as keratinocytes in the mouse skin model of two-stage carcinogenesis
31. Functional analysis of mononuclear cells infiltrating into tumors. V. A soluble factor involved in the regulation of cytotoxic/suppressor T cell infiltration into tumors